Imiglucerase

DB00053

biotech approved

Deskripsi

Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues.

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 3.6-10.4 min
Volume Distribusi * 0.09 to 0.15 L/kg
Klirens (Clearance) * 14.5 +/- 4.0 mL/min/kg

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Target Protein

Glucocerebroside

Referensi & Sumber

Artikel (PubMed)

Contoh Produk & Brand

Produk: 7 • International brands: 0
Produk
  • Cerezyme
    Injection, powder, lyophilized, for solution • 40 U/1mL • Intravenous • US • Approved
  • Cerezyme
    Injection, powder, lyophilized, for solution • 40 U/1mL • Intravenous • US • Approved
  • Cerezyme
    Powder, for solution • 400 unit / vial • Intravenous • Canada • Approved
  • Cerezyme
    Powder, for solution • 200 unit / vial • Intravenous • Canada • Approved
  • Cerezyme
    Injection, powder, for solution • 400 U • Intravenous • EU • Approved
  • Cerezyme
    Injection, powder, for solution • 400 U • Intravenous • EU • Approved
  • Cerezyme
    Injection, powder, for solution • 400 U • Intravenous • EU • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul